SHR1459 in Combination With YY-20394 in Recurrent and Refractory B-cell Non-Hodgkin's Lymphoma
Clinical trial NCT04948788 · UNKNOWN
Trial details
- NCT number
- NCT04948788
- Sponsor
- Jiangsu HengRui Medicine Co., Ltd.
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-10-01
- Primary completion
- 2023-04-01
- Enrollment
- 102
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.